Subscribe To
EFTR / eFFECTOR Therapeutics to Participate in Upcoming Investor Conferences
EFTR News
By PennyStocks
August 24, 2023
Best Penny Stocks To Buy Under $1.25? 3 To Watch Now
Are you looking for the best penny stocks to buy? You're not alone; many traders are showing a renewed interest in this exciting market. more_horizontal
By PennyStocks
June 7, 2023
Best Penny Stocks To Buy? 5 With Big News This Week
Are you searching for some of the best penny stocks to buy now? I'm sure that if you're reading this article, that's something at the top of your mind more_horizontal
By InvestorPlace
May 26, 2023
Why Is eFFECTOR Therapeutics (EFTR) Stock Up 75% Today?
EFFECTOR Therapeutics (NASDAQ: EFTR ) stock is taking off on Friday after the company reported positive data from a Phase 2 clinical trial. This inclu more_horizontal
By GlobeNewsWire
March 28, 2023
eFFECTOR Therapeutics to Participate in Upcoming Investor Conferences
SOLANA BEACH, Calif. and REDWOOD CITY, Calif., March 28, 2023 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR), a leader in the developm more_horizontal
By GlobeNewsWire
January 30, 2023
eFFECTOR Therapeutics to Present at 2023 BIO CEO & Investor Conference
SOLANA BEACH, Calif. and REDWOOD CITY, Calif., Jan. 30, 2023 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR), a leader in the developme more_horizontal
By GlobeNewsWire
February 9, 2022
eFFECTOR Therapeutics to Present at 2022 BIO CEO & Investor Conference
SAN DIEGO and REDWOOD CITY, Calif., Feb. 09, 2022 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics (NASDAQ: EFTR), a biopharmaceutical company focused on pio more_horizontal
By GlobeNewsWire
February 9, 2022
eFFECTOR Therapeutics to Present at 2022 BIO CEO & Investor Conference
SAN DIEGO and REDWOOD CITY, Calif., Feb. 09, 2022 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics (NASDAQ: EFTR), a biopharmaceutical company focused on pio more_horizontal
By GlobeNewsWire
February 9, 2022
eFFECTOR Therapeutics to Present at 2022 BIO CEO & Investor Conference
SAN DIEGO and REDWOOD CITY, Calif., Feb. 09, 2022 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics (NASDAQ: EFTR), a biopharmaceutical company focused on pio more_horizontal